These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 27129150)

  • 21. Visualization of the Breakdown of the Axonal Transport Machinery: a Comparative Ultrastructural and Immunohistochemical Approach.
    Rühling S; Kramer F; Schmutz S; Amor S; Jiangshan Z; Schmitz C; Kipp M; Hochstrasser T
    Mol Neurobiol; 2019 Jun; 56(6):3984-3998. PubMed ID: 30238390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute axonal damage in three different murine models of multiple sclerosis: A comparative approach.
    Höflich KM; Beyer C; Clarner T; Schmitz C; Nyamoya S; Kipp M; Hochstrasser T
    Brain Res; 2016 Nov; 1650():125-133. PubMed ID: 27592741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
    Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
    Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LINGO-1 siRNA nanoparticles promote central remyelination in ethidium bromide-induced demyelination in rats.
    Youssef AEH; Dief AE; El Azhary NM; Abdelmonsif DA; El-Fetiany OS
    J Physiol Biochem; 2019 Feb; 75(1):89-99. PubMed ID: 30759305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Axonal mitochondria adjust in size depending on g-ratio of surrounding myelin during homeostasis and advanced remyelination.
    Ineichen BV; Zhu K; Carlström KE
    J Neurosci Res; 2021 Mar; 99(3):793-805. PubMed ID: 33368634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Axonal stress kinase activation and tau misbehavior induced by kinesin-1 transport defects.
    Falzone TL; Stokin GB; Lillo C; Rodrigues EM; Westerman EL; Williams DS; Goldstein LS
    J Neurosci; 2009 May; 29(18):5758-67. PubMed ID: 19420244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease.
    Yamamoto S; Yamashina K; Ishikawa M; Gotoh M; Yagishita S; Iwasa K; Maruyama K; Murakami-Murofushi K; Yoshikawa K
    J Neuroinflammation; 2017 Jul; 14(1):142. PubMed ID: 28732510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia.
    Pott F; Gingele S; Clarner T; Dang J; Baumgartner W; Beyer C; Kipp M
    Brain Res; 2009 Dec; 1305():137-49. PubMed ID: 19799876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demyelination increases radial diffusivity in corpus callosum of mouse brain.
    Song SK; Yoshino J; Le TQ; Lin SJ; Sun SW; Cross AH; Armstrong RC
    Neuroimage; 2005 May; 26(1):132-40. PubMed ID: 15862213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in the early stage of 5XFAD mice.
    Wu D; Tang X; Gu LH; Li XL; Qi XY; Bai F; Chen XC; Wang JZ; Ren QG; Zhang ZJ
    CNS Neurosci Ther; 2018 May; 24(5):381-393. PubMed ID: 29427384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced axonopathy and enhanced remyelination after chronic demyelination in fibroblast growth factor 2 (Fgf2)-null mice: differential detection with diffusion tensor imaging.
    Tobin JE; Xie M; Le TQ; Song SK; Armstrong RC
    J Neuropathol Exp Neurol; 2011 Feb; 70(2):157-65. PubMed ID: 21343885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination.
    Lindner M; Fokuhl J; Linsmeier F; Trebst C; Stangel M
    Neurosci Lett; 2009 Apr; 453(2):120-5. PubMed ID: 19356606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roles of Adenosine Receptor (subtypes A
    Adebiyi OE; Bynoe MS
    Mol Neurobiol; 2023 Oct; 60(10):5878-5890. PubMed ID: 37358743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring Dimethylsulfoniopropionate as a potential treatment for Alzheimer's disease: A study using the 3 × Tg-AD mouse model.
    Sun F; Huang X; Wang H; Lin B; Li H; Wang X; Liu Q
    Phytomedicine; 2024 Jul; 130():155788. PubMed ID: 38838634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
    Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
    Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring demyelination and remyelination by magnetization transfer imaging in the mouse brain at 9.4 T.
    Zaaraoui W; Deloire M; Merle M; Girard C; Raffard G; Biran M; Inglese M; Petry KG; Gonen O; Brochet B; Franconi JM; Dousset V
    MAGMA; 2008 Sep; 21(5):357-62. PubMed ID: 18779984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfer of myelin-reactive th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice.
    Baxi EG; DeBruin J; Tosi DM; Grishkan IV; Smith MD; Kirby LA; Strasburger HJ; Fairchild AN; Calabresi PA; Gocke AR
    J Neurosci; 2015 Jun; 35(22):8626-39. PubMed ID: 26041928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
    Acs P; Komoly S
    Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells.
    Mi S; Miller RH; Tang W; Lee X; Hu B; Wu W; Zhang Y; Shields CB; Zhang Y; Miklasz S; Shea D; Mason J; Franklin RJ; Ji B; Shao Z; Chédotal A; Bernard F; Roulois A; Xu J; Jung V; Pepinsky B
    Ann Neurol; 2009 Mar; 65(3):304-15. PubMed ID: 19334062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice.
    Goldberg J; Clarner T; Beyer C; Kipp M
    J Mol Neurosci; 2015 Oct; 57(2):166-75. PubMed ID: 26067430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.